AI assistant
Sending…
GENTEX CORP — Director's Dealing 2016
Jan 5, 2016
30893_dirs_2016-01-05_0eb7a9c5-2f49-4aa2-bccb-88ecf205d913.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2015-12-31
Reporting Person: Ryan Scott P (General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-31 | Common Stock | A | 1650 | $0.00 | Acquired | 6744 | Direct |
| 2015-12-31 | Common Stock | A | 197 | $13.61 | Acquired | 6941 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | Employee Stock Option (Right to Buy) | $16.01 | A | 4580 | Acquired | 2022-12-31 | Common Stock (4580) | Direct |
Footnotes
F1: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan.
F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan.
F3: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.
F4: Options granted under the Gentex Corporation Employee Stock Option Plan, which is a Rule 16B-3 Plan.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19